Pseudoscience in the investment context refers to analytical methods, market claims, or investment products that are presented with the language and appearance of rigorous scientific or quantitative analysis but that lack the fundamental requirements of genuine scientific evidence: reproducibility, out-of-sample validation, transparency of methodology, and a plausible theoretical mechanism for the claimed effect. Distinguishing genuine evidence-based investment research from investment pseudoscience is one of the most important skills for sophisticated investors.

Common Investment Pseudoscience

Investment pseudoscience takes many forms. Backtested returns constructed with hindsight bias — selecting parameters, markets, and time periods that happen to produce attractive historical results — are a form of pseudoscience when presented as evidence of future performance. Technical patterns that have never been rigorously tested out-of-sample but are claimed to have reliable predictive value fall into the same category. Investment products marketed with complex jargon and impressive-looking charts that obscure the simplicity of the underlying strategy and the lack of genuine edge are a persistent form of financial pseudoscience.

The Litmus Tests

Several questions distinguish genuine investment science from pseudoscience. Is the methodology fully transparent and independently reproducible? Were the results tested on data that was not used in the development of the strategy? Does the strategy work across multiple markets, asset classes, and time periods — not just in one carefully selected example? Is there a compelling theoretical explanation for why the claimed edge should persist? Are statistical tests appropriate for the sample size and number of tests performed? If the answers to these questions are unclear or evasive, caution is warranted.

---